Syringes

Clayens, a global leader in plastic injection and machining, continues its journey of innovation by integrating a new technology into its portfolio: Thixomolding. This technological diversification is the result of a recent acquisition based in Loveland , Colorado, USA. Thixomolding is a semi-solid magnesium injection technique that combines the intrinsic characteristics of the material with the productivity of injection technology derived from thermoplastics. This technology enables the molding of thin-walled parts, granting them an unparalleled strength/weight ratio. The tolerances achieved through this technology are competing with the best thermoplastics, through a Net Shape transformation process. Magnesium, being one of the most common and abundant elements on Earth and 100% recyclable, positions itself in the class of sustainable materials with low environmental impact. The strength of Thixomolding lies in its ability to harness magnesium, a naturally light metal. This characteristic enables the design of more ergonomic and manageable medical devices, thus enhancing their utility. Additionally, parts produced through this method combine lightness with remarkable sturdiness, ensuring not only an extended lifespan of the devices but also heightened reliability, thereby minimizing risks linked to potential malfunctions. The range of medical applications for products manufactured at our Loveland plant spans from advanced electromedical systems and surgical robots to protective gear and oxygen concentrators. | Injectable drug delivery systems (primary packaging) Leading pharmaceutical companies request our expertise for the manufacture of injectable drug delivery systems. In particular, we manufacture auto-injectors (for the injection of viscous drugs, as well as for the injection of emergency treatments). Our know-how also extends to primary packaging. We are able to meet the most stringent requirements for injectable drug delivery systems, as demonstrated by our ready-to-fill COC syringe.